The efficacy of the use of cannabidiol in the treatment of children with Autism Spectrum Disorder
DOI:
https://doi.org/10.56294/neuro2025210Keywords:
cannabidiol, autism spectrum disorder, pharmacological treatment, medicinal cannabis, childrenAbstract
Introduction: Autism spectrum disorder (ASD) is a neurobiological developmental disorder that affects a significant proportion of the pediatric population. Conventional pharmacological treatment does not always effectively alleviate behavioral and emotional symptoms. In this context, cannabidiol (CBD), a cannabis-derived compound, has been proposed as a therapeutic alternative. This article reviews the literature on the use of CBD in children with ASD and evaluates its efficacy and safety.
Material and methods: A systematic review of clinical studies and reviews on the use of CBD in the treatment of ASD in pediatric population was performed. We selected studies published between 2018 and 2024 that reported on the effects of CBD on ASD symptoms, such as repetitive behavior, anxiety, and difficulties in social communication.
Results: The studies included in this review showed promising results in reducing behavioral and emotional symptoms in children with ASD treated with CBD. However, we highlighted the need for more controlled research with larger samples and longer follow-ups to confirm these findings.
Conclusion: CBD has therapeutic potential in the treatment of ASD symptoms, especially behavioral and emotional problems. Despite the positive preliminary results, further rigorous studies are required to establish clear guidelines for its use in clinical practice.
References
Wade DT, Makela P, Robson P, House H, Bateman C. ¿Los extractos medicinales a base de cannabis tienen efectos generales o específicos sobre los síntomas de la esclerosis múltiple? Un estudio doble ciego, aleatorizado y controlado con placebo en 160 pacientes. Mult Scler J. 2004;10:434-41.
Mackie K. Mecanismos de señalización del receptor CB1: modulación endocannabinoide de la fuerza sináptica. Int J Obes. 2006;30.
Organización Mundial de la Salud. Autismo - OMS. [Internet]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/autism-spectrum-disorders
Zeidan J, Fombonne E, Scorah J, Durkin MS, Saxena S, Deere K, et al. Global prevalence of autism: A systematic review update. Autism Res. 2022 Mar;15(3):191-206.
Ríos MX, Pesántez MX, et al. Utilización de cannabidiol en un paciente pediátrico con trastorno del espectro autista y epilepsia: Informe de caso. Rev Ecuat Pediatr. 2021;22(2):1-8.
Colacite J, et al. Uso de cannabidiol en el tratamiento del autismo: revisión de la literatura y perspectivas futuras. Res Soc Dev. 2024;13(3):e5113341741.
Da Silva CNS, Da Silva TMB. Atenção farmacêutica no uso do canabidiol em tratamento de crianças com Transtorno do Espectro Autista (TEA). Cognit Sci J. 2024;7(2):e529.
Da Cunha GAR, et al. O uso de canabidiol (CBD) em pacientes pediátricos com transtorno do espectro autista. Rev Pró-UniverSUS. 2022;13(2):40-43.
Álvarez F, et al. Uso de derivados de cannabis medicinal en una población pediátrica en Uruguay durante 2019-2021. An Fac Med. 2022.
Castro NIQ, Cobo AE, Rodríguez PN. Eficacia de los cannabinoides en los síntomas del trastorno de espectro autista: una revisión sistemática. Rev Inf Científica. 2024;103(1 Sup):45-48.
Freire LEM, et al. Transtorno do Espectro Autista: uso da cannabis em pacientes pediátricos. Junior Doctors. 2024;77.
Barchel D, et al. Oral cannabidiol use in children with autism spectrum disorder to treat related symptoms and co-morbidities. Front Pharmacol. 2019;9:1521.
Pedrazzi JFC, et al. Cannabidiol for the treatment of autism spectrum disorder: hope or hype? Psychopharmacology. 2022;239(9):2713-2734.
Poleg S, et al. Cannabidiol as a suggested candidate for treatment of autism spectrum disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2019;89:90-96.
Aran A, et al. Brief report: cannabidiol-rich cannabis in children with autism spectrum disorder and severe behavioral problems—a retrospective feasibility study. J Autism Dev Disord. 2019;49(3):1284-1288.
Aran A, et al. Cannabinoid treatment for autism: a proof-of-concept randomized trial. Mol Autism. 2021;12:1-11.
Salgado CA, Castellanos D. Autism spectrum disorder and cannabidiol: have we seen this movie before? Glob Pediatr Health. 2018;5:2333794X18815412.
Ma L, Platnick S, Platnick H. Cannabidiol in treatment of autism spectrum disorder: a case study. Cureus. 2022;14(8).
Agarwal R, Burke SL, Maddux M. Current state of evidence of cannabis utilization for treatment of autism spectrum disorders. BMC Psychiatry. 2019;19(1):328.
Published
Issue
Section
License
Copyright (c) 2025 Brício Barbosa Ferreira, Patricia Salguero (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
